Institute for International Research

Scientific Advisory Committee

• Mark Chang, Ph.D., Scientific Fellow, Millennium Pharmaceuticals
• Michael Krams, M.D., Assistant Vice President, Adaptive Trials, Clinical Development, Wyeth Research
• Jerald S. Schindler, Dr. P.H., Vice President, Biostatistics and Research Decision Sciences, Late Stage Clinical Development Statistics, Merck Research Laboratories
• Paul Gallo, Ph.D., Director Biostatistics, Novartis Pharmaceuticals
• Judith Quinlan, Ph.D., Director Statistics, GlaxoSmithKline
• Ulrika Simonsson, Ph.D., Senior Research Scientist, AstraZeneca

Distinguished Faculty

• Zoran Antonijevic, MS, Senior Director, Strategic Development/Biostatistics, Quintiles
• Michael Borkowski, General Manager of Clinical Technologies, United BioSource Corporation
• Nancy Burnham, Manager, Statistics, GlaxoSmithKline
• Daniel Burns, Ph.D., Director, Adaptive Trials, Clinical Development, Wyeth Research
• Mark Chang, Ph.D., Scientific Fellow, Millennium Pharmaceuticals
• Vladimir Dragalin, Ph.D., Senior Director, Global Biostatistics, Wyeth Research
• Greg Enas, Ph.D., Director, US Regulatory Affairs, Eli Lilly
• Scott Gottlieb M.D., Resident Fellow, American Enterprise Institute
• Patrick Kelly, Ph.D., Technical and Scientific Development Leader, AstraZeneca
• Olga V. Marchenko, Director, Biostatistics Consulting, Oncology, i3 Statprobe
• Cyrus R. Mehta, Ph.D., President and Co-Founder, Cytel Inc.
• Daniel Normelle, Ph.D., Associate Professor, Department of Radiation Oncology, University of Michigan
• Judith Quinlan, Ph.D., Director Statistics, GlaxoSmithKline
• Mark Rothmann, Ph.D., Lead Math Statistician, Division of Biometrics, FDA
• Bruce Turnbull, Ph.D., Professor of Statistics, Cornell University
• Gernot Wassmer, Ph.D., Associate Professor for Biostatistics, University of Cologne, Germany